Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Alamy Stock Photo

Walmart offers to pay $3.1 billion to settle opioid lawsuits

The proposal follows similar announcements earlier in November from the two largest US pharmacy chains, CVS Health and Walgreen Co.

RETAIL GIANT WALMART has become the latest major player in the drug industry to announce a plan to settle lawsuits filed by state and local governments over the toll of powerful prescription opioids sold at its pharmacies across the US.

The $3.1 billion (€3 billion) proposal follows similar announcements earlier in November from the two largest US pharmacy chains, CVS Health and Walgreen Co, which each said they would pay about $5 billion (€4.8 billion).

Arkansas-based Walmart said in a statement that it “strongly disputes” allegations in lawsuits from state and local governments that its pharmacies improperly filled prescriptions for the powerful prescription painkillers. The company does not admit liability with the settlement plan.

New York Attorney General Letitia James said in a release that the company would have to comply with oversight measures, prevent fraudulent prescriptions and flag suspicious ones.

Lawyers representing local governments said the company would pay most of the settlement over the next year if it is finalised.

The deals are the product of negotiations with a group of state attorneys general, but they are not final.

The CVS and Walgreens deals would have to be accepted first by a critical mass of state and local governments before they are completed. Walmart’s plan would have to be approved by 43 states. The formal process has not yet begun.

The national pharmacies join some of the biggest drugmakers and drug distributors in settling complex lawsuits over their alleged roles in an opioid overdose epidemic that has been linked to more than 500,000 deaths in the US over the past two decades.

The tally of proposed and finalised settlements in recent years is more than $50 billion (€48.2 billion), with most of that to be used by governments to combat the crisis.

In the 2000s, most fatal opioid overdoses involved prescription drugs such as OxyContin and generic oxycodone. After governments, doctors and companies took steps to make them harder to obtain, people addicted to the drugs increasingly turned to heroin, which proved more deadly.

In recent years, opioid deaths have soared to record levels around 80,000 a year. Most of those deaths involve illicitly produced version of the powerful lab-made drug fentanyl, which is appearing throughout the US supply of illegal drugs.

Close
Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel

     
    JournalTv
    News in 60 seconds